These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quantitative and qualitative changes in lipids, lipoproteins, apolipoprotein A-I, and sex hormone-binding globulin due to two doses of conjugated equine estrogen with and without a progestin. Miller VT, Muesing RA, LaRosa JC, Stoy DB, Fowler SE, Stillman RJ. Obstet Gynecol; 1994 Feb; 83(2):173-9. PubMed ID: 8290177 [Abstract] [Full Text] [Related]
3. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women. Bayrak A, Aldemir DA, Bayrak T, Corakçi A, Dursun P. Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536 [Abstract] [Full Text] [Related]
4. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy. Kim CJ, Min YK, Ryu WS, Kwak JW, Ryoo UH. Arch Intern Med; 2006 Aug; 156(15):1693-700. PubMed ID: 8694668 [Abstract] [Full Text] [Related]
5. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations. Whitcroft SI, Crook D, Marsh MS, Ellerington MC, Whitehead MI, Stevenson JC. Obstet Gynecol; 1994 Aug; 84(2):222-6. PubMed ID: 8041534 [Abstract] [Full Text] [Related]
7. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus. Araújo DA, Farias ML, Andrade AT. Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087 [Abstract] [Full Text] [Related]
9. [Effect of conjugated estrogen and Org OD14 on serum lipoprotein and apolipoprotein in perimenopausal and postmenopausal women]. Bai W, Yang X, Zheng S. Zhonghua Fu Chan Ke Za Zhi; 1999 May; 34(5):293-6. PubMed ID: 11326938 [Abstract] [Full Text] [Related]
15. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study. Chang TC, Lien YR, Chen M, Cheng SP, Chen RJ, Chow SN. Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192 [Abstract] [Full Text] [Related]
16. Effects of progestogen on lipids, lipoproteins and apolipoproteins during transdermal estrogen replacement therapy with and without medroxyprogesterone acetate. Castelo-Branco C, Casals E, Sanllehy C, Duran M, Fortuny A, Vanrell JA. J Reprod Med; 1996 Nov; 41(11):833-8. PubMed ID: 8951134 [Abstract] [Full Text] [Related]
18. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy. Pan HA, Wang ST, Chen CH, Pai MC, Wu MH, Huang KE. Climacteric; 2002 Sep; 5(3):259-65. PubMed ID: 12419084 [Abstract] [Full Text] [Related]
19. Assessment of less than monthly progestin therapy in postmenopausal women given estrogen replacement. Williams DB, Voigt BJ, Fu YS, Schoenfeld MJ, Judd HL. Obstet Gynecol; 1994 Nov; 84(5):787-93. PubMed ID: 7936513 [Abstract] [Full Text] [Related]
20. Effect of oral and transdermal hormone replacement therapy on lipid profile and Lp(a) level in menopausal women with hypercholesterolemia. Perrone G, Stefanutti C, Galoppi P, Anelli G, Capri O, Lucani G, Vivenzio A, Mazzarella B, Zichella L. Int J Fertil Menopausal Stud; 1996 Nov; 41(6):509-15. PubMed ID: 9010744 [Abstract] [Full Text] [Related] Page: [Next] [New Search]